Obesity and hypertension.
Seravalle G, Grassi G.
Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19.
Obesity, Adipose Tissue and Vascular Dysfunction.
Koenen M, Hill MA, Cohen P, Sowers JR.
Circ Res. 2021 Apr 2;128(7):951-968. doi: 10.1161/CIRCRESAHA.121.318093. Epub 2021 Apr 1.
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.
Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA.
J Clin Oncol. 2016 Dec 10;34(35):4270-4276. doi: 10.1200/JCO.2016.67.4283. Epub 2016 Nov 7.
Adipose Tissue Fibrosis in Obesity: Etiology and Challenges.
Marcelin G, Gautier EL, Clément K.
Annu Rev Physiol. 2022 Feb 10;84:135-155. doi: 10.1146/annurev-physiol-060721-092930. Epub 2021 Nov 9.
Obesity, white adipose tissue and cancer.
Solsona-Vilarrasa E, Vousden KH.
FEBS J. 2025 May;292(9):2189-2207. doi: 10.1111/febs.17312. Epub 2024 Nov 4.
Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis.
Marcelin G, Silveira ALM, Martins LB, Ferreira AV, Clément K.
J Clin Invest. 2019 Oct 1;129(10):4032-4040. doi: 10.1172/JCI129192.
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.
Eur Cytokine Netw. 2006 Mar;17(1):4-12.
Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Steinert RE, Feinle-Bisset C, Asarian L, Horowitz M, Beglinger C, Geary N.
Physiol Rev. 2017 Jan;97(1):411-463. doi: 10.1152/physrev.00031.2014.
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.
Wajchenberg BL.
Endocr Rev. 2000 Dec;21(6):697-738. doi: 10.1210/edrv.21.6.0415.
Obesity Enables NLRP3 Activation and Induces Myocardial Fibrosis via Hyperacetylation of HADHa.
Deng Y, Liu X, Xie M, Zhao R, Ji L, Tang K, Yang W, Ou W, Xie M, Li T.
Diabetes. 2023 Nov 1;72(11):1597-1608. doi: 10.2337/db23-0264.
